olinvyk

Generic: oliceridine

olinvyk: developed by 1 company · 1 FDA decision. Updated within the last hour.

Development Pipeline (1)

CompanyPhase
TREVENA INC (TRVN)Approved

FDA Decisions

Approval1 INDICATIONS AND USAGE OLINVYK is indicated in adults for the management of acute pain severe enough to require an intravenous opioid analgesic and for whom alternative treatments are inadequate. Limitations of Use Because of the risks of addiction, abuse, misuse, overdose, and death, which can occur at any dosage or duration [see Warnings and Precautions ( 5.1 )] , and persist over the course of therapy, reserve opioid analgesics, including OLINVYK, for use in patients for whom alternative tre(TRVN)

Frequently asked questions

Who is developing olinvyk?

olinvyk is being developed by TREVENA INC.

What is olinvyk's latest FDA decision?

The most recent tracked FDA decision for olinvyk is Approval for 1 INDICATIONS AND USAGE OLINVYK is indicated in adults for the management of acute pain severe enough to require an intravenous opioid analgesic and for whom alternative treatments are inadequate. Limitations of Use Because of the risks of addiction, abuse, misuse, overdose, and death, which can occur at any dosage or duration [see Warnings and Precautions ( 5.1 )] , and persist over the course of therapy, reserve opioid analgesics, including OLINVYK, for use in patients for whom alternative tre, dated August 7, 2020.

Get deeper analysis on olinvyk

Full trial data, mechanism of action, competitive landscape, and AI-powered insights.

Start Free Analysis
    olinvyk — Drug Pipeline, Trials & FDA Status | BioSniper